HDIN Research projects the global medical MRI market will reach **$14.3 billion by 2031**, growing at a **4.2%–5.8% CAGR** from a 2026 baseline of **$9.2–10.8 billion**. The sector is shifting toward **helium-free systems** and **ultra-high-field MRI technology**, driven by rising demand from an aging population—**6.8 million annual deaths** are linked to neurological disorders, increasing diagnostic needs.

Sep 2026hdinresearch.comNews article

Beijing Wandong Medical Technology Co., Ltd. finalizes a CNY 59.99 million equity buyback, repurchasing 4,499,796 shares (0.64% of outstanding stock) under a plan announced in August 2025. The initiative concludes ahead of its June 2026 expiration date. The company operates in the medical technology sector.

Jun 2026MarketScreenerNews article

Wandong Medical collaborates with the Chinese Academy of Sciences (CAS) to develop domestically produced high-field MRI systems without liquid helium. The partnership supports China’s efforts to reduce reliance on imported medical technology components and advance self-sufficient innovation in advanced healthcare equipment.

Oct 2025NotizieNews article

Beijing Wandong Medical Technology Co.,Ltd. repurchases up to **2.4 million shares** for **CNY 60 million** under a new equity buyback program. The company plans to acquire shares at **CNY 25 per share** through the initiative. The move aims to optimize shareholder structure and potentially boost stock value.

Aug 2025MarketScreenerNews article